Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 22Neoplasms 13Colonic Neoplasms 10Breast Neoplasms 10Venous Thromboembolism 8Prostatic Neoplasms 8Multiple Myeloma 7Recurrence 6Polycythemia Vera 6Carcinoma, Non-Small-Cell Lung 6Thrombocythemia, Essential 4Neoplasms, Plasma Cell 4Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Thrombosis 2Sarcoma 2Rectal Neoplasms 2Primary Myelofibrosis 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms by Site 2Myocardial Infarction 2Lung Neoplasms 2Intestinal Neoplasms 2Intestinal Diseases 2Inflammation 2Gastrointestinal Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2

Interventions

Sirolimus 13Everolimus 12Vigabatrin 3Activator Appliances 3carbon-11 acetate 1Urination 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Simvastatin 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Propranolol 1Phlebotomy 1Genetic Testing 1Fluid Therapy 1Doxycycline 1Curcumin 1Calcitriol 1Aspirin 1Anticonvulsants 1Actigraphy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Tuberous Sclerosis × Aspirin × Clear all
NCT03356769 2020-06-09

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Peking Union Medical College Hospital

Phase 2 Unknown
98 enrolled

Epilepsy, Seizures, Tuberous Sclerosis, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡